Mirum Pharmaceuticals Inc... (MIRM)
NASDAQ: MIRM
· Real-Time Price · USD
68.25
3.42 (5.28%)
At close: Aug 15, 2025, 1:13 PM
5.28% (1D)
| Bid | 68.09 |
| Market Cap | 3.43B |
| Revenue (ttm) | 429.16M |
| Net Income (ttm) | -58.56M |
| EPS (ttm) | -1.21 |
| PE Ratio (ttm) | -56.41 |
| Forward PE | -127.46 |
| Analyst | Buy |
| Ask | 68.48 |
| Volume | 546,573 |
| Avg. Volume (20D) | 489,708 |
| Open | 64.87 |
| Previous Close | 64.83 |
| Day's Range | 64.33 - 69.00 |
| 52-Week Range | 36.86 - 69.00 |
| Beta | 0.95 |
About MIRM
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol MIRM
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for MIRM stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsEarnings Surprise
Mirum Pharmaceuticals has released their quartely earnings
on Aug 6, 2025:
Next Earnings Release
Mirum Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 11, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+12.04%
Mirium Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
1 week ago
+2.99%
Mirium Pharmaceuticals shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY25 sales guidance above estimates.
